Johnson & Johnson Newsroom

Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Businesswire05:30

Jim Cramer Says This CEO 'Built An Amazing Company,' Recommends Buying Netflix

BenzingaDec 12 21:55

U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients

PR NewswireDec 12 21:30

Today's Analyst Rating | Citi Cuts Its Price Target Cut on Johnson & Johnson to $175, Deutsche Bank Upgrades Coca-Cola to Buy

Dec 12, Wall Street analysts have updated their stock ratings today including $Johnson & Johnson(JNJ.US)$ and $Coca-Cola(KO.US)$.

Futu NewsDec 12 21:00 · Ratings

Bank of America resumes coverage of Johnson & Johnson with a Target Price of $166.

Gelonghui, December 12 | Bank of America: Resumes coverage of Johnson & Johnson, giving it a "neutral" rating, with a Target Price of $166. (Gelonghui)

Gelonghui FinanceDec 12 16:16 · Ratings

Latest research results on Johnson & Johnson (JNJ.US) CAR-T therapy announced

Johnson & Johnson (JNJ.US) recently announced the latest research results of the phase 3 clinical trial CARTITUDE-4.

Zhitong FinanceDec 12 08:03

Express News | Citigroup has lowered the Target Price for Johnson & Johnson from $185.00 to $175.00.

BreakingsDec 12 03:26

Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Cuts Target Price to $175

Futu NewsDec 11 20:31 · Ratings

Express News | J&J : Citigroup Cuts Target Price to $175 From $185

BreakingsDec 11 20:18

Investors in Johnson & Johnson (NYSE:JNJ) Have Unfortunately Lost 4.4% Over the Last Three Years

Simply Wall StDec 11 19:49

Why Is Johnson & Johnson (JNJ) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?

Yahoo FinanceDec 11 12:20

BofA Restarts Coverage of 11 Large-cap Biopharmas

Seeking AlphaDec 11 06:01

GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex

BenzingaDec 11 02:14

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaDec 11 01:35

The Analyst Landscape: 15 Takes On Johnson & Johnson

BenzingaDec 10 23:01

Press Release: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

Dow JonesDec 10 21:04

B of A Securities Reinstates Neutral on Johnson & Johnson, Announces $166 Price Target

BenzingaDec 10 20:41 · Ratings

Johnson & Johnson Analyst Ratings

BenzingaDec 10 20:40 · Ratings

Johnson & Johnson's Carvykti Shows Promising Late-Stage Study Results for Multiple Myeloma

MT NewswiresDec 10 19:08

EU Specialty Pharma to See Product Launches But Limited Clinical Data Next Year -- Market Talk

WSJDec 10 15:05